Agenda

  • European Commission's approval of financing for the Accelerate.EU project

  • Official public announcement of the project

  • Kick-off meeting in Hamburg

  • Production capacity and production schedules mapped out to ensure 211At availability for (pre)clinical trials

  • IDMC for pilot study 211At-Sub P GBM created

  • Pilot study 211At-Sub P GBM initiation

  • Pilot study 211At-Sub P GBM Regulatory and Ethics approval received

  • IDMC for Phase 1 123I/211At-DualFAPi mTNBC created

  • IMPD for Phase 1 123I/211At-DualFAPi mTNBC

  • Phase 1 123I/211At-DualFAPi mTNBC Regulatory and Ethics approval received

  • Phase 1 123I/211At-DualFAPi mTNBC initiation

  • Last patient – last visit 211At for both clinical trials

  • Successful completion of co-clinical framework